Skip to McMaster Navigation
Skip to Site Navigation
Skip to main content
McMaster logo
Juravinski Research Institute
Search button
Menu button
Main Menu
Home
About the Institute
Research Projects
In the News
Publications
Donate
Home
In the News
Second dose of AstraZeneca COVID-19 vaccine: FAQs about blood clots, safety, risks and symptoms
Second dose of AstraZeneca COVID-19 vaccine: FAQs about blood clots, safety, risks and symptoms
Posted on May 31, 2021
Share
Twitter
Facebook
LinkedIn
Read more at
The Conversation
.
In the News
